T akotsubo syndrome (TTS), also known as broken heart syndrome or stress-induced cardiomyopathy, is a severe but reversible acute heart failure syndrome that predominantly affects post-menopausal women (1,2). This condition results from a surge in catecholamines (3) that typically occurs in situations of physical or emotional stress (2), or even during happy events such as wed- Despite the usual recovery from TTS within days to weeks of the incidence, the profound contractile deficit that defines TTS can lead to serious complications, including cardiogenic shock, thrombi formation, ventricular wall rupture, pulmonary edema, and arrhythmia. This results in a significant mortality rate of 4% to 5%, which is also comparable to the in-hospital rate of acute myocardial infarction (1,2). Beyond the initial contractile deficit, the long-term sequelae seem to involve cardiac inflammation.
TTS closely resemble those with acute myocardial infarction, presenting most frequently with STsegment elevation on electrocardiography and chest pain (2); however, there is an absence of culprit coronary artery disease. It is only with recently increasing interest that TTS is becoming routinely recognized.
Despite the usual recovery from TTS within days to weeks of the incidence, the profound contractile deficit that defines TTS can lead to serious complications, including cardiogenic shock, thrombi formation, ventricular wall rupture, pulmonary edema, and arrhythmia. This results in a significant mortality rate of 4% to 5%, which is also comparable to the in-hospital rate of acute myocardial infarction (1,2).
It has recently been recognized that despite the apparent recovery, patients with TTS develop longterm contractile dysfunction (6) . Despite an increasing understanding of the disease course of TTS, there is currently no evidence-based treatment in the acute phase, or for the chronic management of these patients (1) .
Although the correlation of TTS with a surge in catecholamines is well-evidenced, there is no established pathophysiologic mechanism. Several hypotheses exist, including direct catecholaminergic myocardial stunning, acute LV outflow tract obstruction, microvascular endothelial dysfunction, multivessel coronary vasospasm, and abnormal lipid metabolism.
TTS has been recapitulated in vivo in preclinical rodent models by bolus injection of high concentration epinephrine, or its analogue isoproterenol (7, 8) .
These articles examine the involvement of the b- Science author instructions page. on magnetic resonance imaging (9) . As this subsides, a process of global microscopic fibrosis develops in its place, which can be detected as early as 4 months (6).
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Therefore, it is important to understand the processes linking the acute changes in contractility with the downstream inflammatory changes that worsen longterm prognosis.
The current authors (10) sudden cardiac death was precipitated even when the systolic dysfunction of TTS was prevented (7, 8) .
In terms of advancing the understanding of TTS, the analysis here takes the story further than the initial insult and starts to address potential mechanisms for ongoing deficits in cardiac function.
Inflammation is clearly key, but the persistence of this and of the possible edema will need to be explored in a more extensive time series study. In terms of potential therapeutic avenues, PARP-1 inhibition did show some benefit for systolic function, although incomplete. It will be important to know whether this is observed if the inhibitor is given after the isoproterenol, because the clinical presentation of TTS is usually some after the catecholamine surge.
However, the lack of effect of PARP-1 inhibitor on the inflammatory state suggests that ongoing inflammation is a problem that may need to be addressed separately in the treatment of these patients. 
